Lataa...
Study Progression on Non-small Cell Lung Cancer with EGFR Mutation Treated by Immune Checkpoint Inhibitors
In recent years, epidermal growth factor receptor tyrosine kinase inhibitors have been recommended by many guidelines as first-line drugs for advanced non-small cell lung cancer (NSCLC) with EGFR gene mutations and no resistance. However, with the prolongation of medication time, most appear acquire...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Chinês |
| Julkaistu: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-08-01
|
| Sarja: | Chinese Journal of Lung Cancer |
| Aiheet: | |
| Linkit: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.08.11 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|